Page last updated: 2024-09-04

phosphorus and decitabine

phosphorus has been researched along with decitabine in 3 studies

Compound Research Comparison

Studies
(phosphorus)
Trials
(phosphorus)
Recent Studies (post-2010)
(phosphorus)
Studies
(decitabine)
Trials
(decitabine)
Recent Studies (post-2010) (decitabine)
48,0741,12617,1393,8042052,177

Protein Interaction Comparison

ProteinTaxonomyphosphorus (IC50)decitabine (IC50)
DNA (cytosine-5)-methyltransferase 1Homo sapiens (human)0.03

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's2 (66.67)2.80

Authors

AuthorsStudies
Azechi, T; Sato, F; Sudo, R; Wachi, H1
Diao, S; DiNardo, C; DiPippo, AJ; Konopleva, M; Maiti, A; Nichols, ED; Ning, J; Qiao, W1
Dharmalingam, P; Tan, B; Venkatakrishnan, K1

Other Studies

3 other study(ies) available for phosphorus and decitabine

ArticleYear
5-aza-2'-Deoxycytidine, a DNA methyltransferase inhibitor, facilitates the inorganic phosphorus-induced mineralization of vascular smooth muscle cells.
    Journal of atherosclerosis and thrombosis, 2014, Volume: 21, Issue:5

    Topics: Alkaline Phosphatase; Aorta; Azacitidine; Blotting, Western; Cell Differentiation; Cells, Cultured; Decitabine; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; DNA Modification Methylases; Enzyme Inhibitors; Humans; Muscle, Smooth, Vascular; Phosphorus; Real-Time Polymerase Chain Reaction; RNA; Vascular Calcification

2014
Incidence of tumor lysis syndrome in patients with acute myeloid leukemia undergoing low-intensity induction with venetoclax.
    American journal of hematology, 2021, 03-01, Volume: 96, Issue:3

    Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bridged Bicyclo Compounds, Heterocyclic; Cytarabine; Decitabine; Female; Fluid Therapy; Humans; Hydroxyurea; Incidence; Leukemia, Myeloid, Acute; Leukemia, Myelomonocytic, Acute; Leukocytosis; Male; Middle Aged; Phosphate-Binding Proteins; Phosphorus; Proto-Oncogene Proteins c-bcl-2; Retrospective Studies; Sulfonamides; Tumor Lysis Syndrome; Urate Oxidase; Uric Acid

2021
Nanoplatform to Investigate Tumor-Initiating Cancer Stem Cells: Breaking the Diagnostic Barrier.
    ACS applied materials & interfaces, 2022, Feb-09, Volume: 14, Issue:5

    Topics: Biomarkers, Tumor; Cell Cycle Checkpoints; Cell Line, Tumor; Decitabine; Epigenesis, Genetic; Humans; Hydroxamic Acids; Lasers; Lung Neoplasms; Nanostructures; Neoplastic Stem Cells; Pancreatic Neoplasms; Phosphorus; Silicon; Spectrum Analysis, Raman

2022